Fosamax Cost in Mississippi 2026: Alendronate Prices, Medicaid, and Savings

Prescription access and medication affordability image for Fosamax Cost in Mississippi 2026: Alendronate Prices, Medicaid, and Savings

At a glance

  • Cash price (generic, MS retail 2026) / ~$15/month
  • Brand Fosamax list price / ~$80/month
  • Mississippi Medicaid coverage / Not covered for standard outpatient use
  • Standard dose / 70 mg oral tablet, once weekly
  • 503A compounded alendronate (MS-licensed pharmacy) / May be available at lower or no cost
  • Telehealth prescribing in Mississippi / Legal and available
  • FDA approval year / 1995 (postmenopausal osteoporosis)
  • FIT trial fracture risk reduction / 47% reduction in hip fracture vs. placebo
  • Generic availability / Yes, multiple manufacturers since 2008

What Does Fosamax Actually Cost in Mississippi in 2026?

Generic alendronate 70 mg (one tablet per week, 4 tablets per month) retails for approximately $15 per month at Mississippi pharmacies when purchased with a GoodRx or similar discount coupon in 2026. Without any coupon, the same generic package may run $20 to $35 depending on the chain. Brand-name Fosamax carries a manufacturer list price near $80 per month, though very few patients pay that figure.

Pricing varies by pharmacy. A 4-tablet supply of alendronate 70 mg in Jackson, MS averages $14 to $17 with a GoodRx coupon at major chains such as Walmart, Walgreens, CVS, and Kroger. Independent pharmacies in rural Mississippi counties, including those in the Delta region, sometimes charge $5 to $10 more than urban chains for the same supply because of lower purchasing volume. Calling ahead with the GoodRx coupon code before driving to a pharmacy is the single most reliable way to confirm price.

Alendronate is available as a 70 mg weekly tablet, a 70 mg effervescent tablet (less common), and a 5 mg or 10 mg daily tablet. The weekly 70 mg formulation is the one most commonly dispensed and the one discussed in most cost comparisons for Mississippi patients. The FDA-approved labeling for alendronate specifies these dose forms and the clinical indications for each. [1]

The Fracture Intervention Trial (FIT), published in JAMA in 1998 (N=2,027 women), showed that alendronate reduced the risk of hip fracture by 47% (relative risk 0.53 to 95% CI 0.31 to 0.87) compared with placebo over 36 months. [2] That clinical evidence underpins why alendronate remains a first-line agent in osteoporosis management and why cost barriers to access carry real health consequences for Mississippi patients.

Does Mississippi Medicaid Cover Alendronate or Fosamax?

Mississippi Medicaid does not cover brand-name Fosamax or generic alendronate for standard outpatient osteoporosis treatment under the 2026 preferred drug list. This is a notable gap given that Mississippi has one of the highest rates of osteoporosis-related fractures among Southern states.

The Mississippi Division of Medicaid administers a Preferred Drug List (PDL) that changes quarterly. As of the 2026 formulary cycle, oral bisphosphonates including alendronate are listed as non-preferred or require prior authorization for most beneficiaries. Patients who receive Mississippi Medicaid and need alendronate should ask their prescriber to submit a prior authorization request documenting a dual-energy X-ray absorptiometry (DEXA) scan result of T-score at or below negative 2.5, a documented fragility fracture, or both. The American Association of Clinical Endocrinology (AACE) 2020 Clinical Practice Guidelines for Diagnosis and Treatment of Postmenopausal Osteoporosis recommend alendronate as a first-line agent for patients with T-score at or below negative 2.5, a point that can support a prior authorization appeal. [3]

Medicaid dual-eligible patients (those covered by both Medicare and Medicaid) may find alendronate covered under a Medicare Part D plan, since generic alendronate sits on Tier 1 or Tier 2 of most Part D formularies. The Centers for Medicare and Medicaid Services (CMS) requires Part D plans to cover at least two drugs in each therapeutic category. [4] Checking the Medicare Plan Finder at medicare.gov before selecting or changing a Part D plan is the most direct route to confirming alendronate tier placement.

Which Mississippi Insurance Plans Cover Fosamax?

Most commercial insurance plans operating in Mississippi, including BlueCross BlueShield of Mississippi, Humana, Aetna, and United Healthcare, cover generic alendronate on Tier 1 or Tier 2 of their formularies, meaning a copay of $5 to $20 per month for most members. Brand Fosamax is rarely covered at preferred tier on any Mississippi commercial plan in 2026; insurers universally require a generic-first step-therapy before approving the brand.

Employer-sponsored plans governed by ERISA follow federal formulary rules rather than Mississippi state insurance mandates, so coverage can differ even among plans sold to Mississippi employers by the same carrier. The American Heart Association notes that bisphosphonate therapy after osteoporotic fracture significantly reduces secondary cardiovascular and fracture events, a finding that some plan medical directors cite when approving prior authorizations. [5]

Patients whose commercial plan places generic alendronate on Tier 3 or higher can request a formulary exception by submitting a letter of medical necessity from their prescribing provider. Providing the FIT trial data and an AACE guideline reference generally strengthens that request. [2][3]

Is Compounded Alendronate Legal in Mississippi?

Yes. A Mississippi-licensed 503A compounding pharmacy can legally prepare alendronate for an individual patient when a licensed prescriber issues a valid, patient-specific prescription. This is governed by Section 503A of the Federal Food, Drug, and Cosmetic Act and is enforceable through both federal FDA oversight and the Mississippi State Board of Pharmacy. [6]

503A compounding differs from 503B outsourcing facilities. A 503A pharmacy compounds for individual patients on a prescription-by-prescription basis and is not permitted to produce large batches for office stock. Compounded alendronate preparations are not FDA-approved, meaning they have not undergone the same efficacy and safety review as the commercial tablet. The FDA has published guidance clarifying that compounded copies of commercially available drugs raise regulatory concerns when the commercial product is readily available. [7] Given that generic alendronate 70 mg is widely available at $15 per month in Mississippi, a clinician would need a documented clinical rationale, such as dysphagia requiring an alternative dose form or a documented allergy to an excipient in the commercial tablet, before a 503A pharmacy should compound it.

When a valid clinical rationale does exist, compounded alendronate may cost less than the commercial generic, and some compounding pharmacies charge minimal dispensing fees for simple formulations. Patients should verify that any pharmacy they use holds an active Mississippi State Board of Pharmacy license before submitting a prescription.

Can I Get a Fosamax Prescription via Telehealth in Mississippi?

Telehealth prescribing of alendronate is legal in Mississippi. Mississippi law permits synchronous audio-visual telehealth visits to establish a valid prescriber-patient relationship, after which a controlled or non-controlled prescription may be issued. Alendronate is not a controlled substance, which removes an additional layer of federal prescribing restriction.

The Mississippi State Department of Health and the Mississippi State Board of Medical Licensure allow telehealth providers licensed in Mississippi to prescribe alendronate following a clinical evaluation that includes review of relevant DEXA scan results and fracture history. [8] Providers licensed in other states must hold a Mississippi telehealth license or operate under reciprocal licensure agreements to prescribe to Mississippi residents.

A telehealth visit for osteoporosis management typically includes review of DEXA T-score, fracture risk assessment using the FRAX tool (developed by the World Health Organization), serum calcium, vitamin D 25-OH level, and renal function (creatinine clearance, since alendronate is contraindicated when creatinine clearance is below 35 mL per minute per the FDA label). [1][9] The National Osteoporosis Foundation (now part of the Bone Health and Osteoporosis Foundation) recommends supplemental calcium (1,000 to 1 to 200 mg per day) and vitamin D (800 to 1 to 000 IU per day) alongside bisphosphonate therapy. [10]

After a telehealth visit, the prescription can be sent electronically to any Mississippi retail pharmacy or a 503A compounding pharmacy. The entire process, from scheduling to pharmacy pickup, can take less than 48 hours for most patients in metropolitan areas like Jackson, Hattiesburg, or Gulfport.

What Savings Programs Apply to Fosamax and Alendronate in Mississippi?

Several overlapping savings mechanisms can bring monthly alendronate cost below $10 for most Mississippi patients. The following programs are worth checking in order of likely savings.

GoodRx and Similar Discount Cards. GoodRx, RxSaver, and Blink Health operate as pharmacy benefit managers that negotiate discount pricing directly with pharmacy chains. Presenting a GoodRx coupon for alendronate 70 mg (4 tablets) at a Mississippi Walmart typically yields a price of $9 to $14. These programs are free to join and require no insurance. The coupon cannot be combined with insurance, so patients should compare the coupon price against their insurance copay before choosing which to use. [11]

Merck Patient Assistance Program. Merck (the manufacturer of brand Fosamax) offers a patient assistance program for uninsured or underinsured patients meeting income criteria, generally at or below 400% of the federal poverty level. Because generic alendronate is widely available at low cost, Merck's program is rarely necessary for the generic, but patients who require brand Fosamax for a documented medical reason can apply through Merck's patient assistance portal. [12]

Medicare Extra Help (Low Income Subsidy). Mississippi residents who qualify for Medicare Extra Help pay no more than $4.50 per generic prescription per month under 2026 subsidy benchmarks. The Social Security Administration administers this program. [13] Alendronate, as a Tier 1 generic on most Part D plans, falls under this cap, making it effectively free for Extra Help recipients.

Mississippi IDA and 340B Programs. Federally Qualified Health Centers (FQHCs) operating in Mississippi participate in the 340B Drug Pricing Program, which allows the facility to purchase alendronate at deeply discounted prices and pass savings to qualifying patients. Rural Mississippians who receive care at an FQHC, such as those operated by the Mississippi Primary Health Care Association, should ask whether alendronate is dispensed through the facility's 340B-linked pharmacy. [14]

How Does Alendronate Work and Why Does Dose Timing Matter for Cost?

Alendronate is a nitrogen-containing bisphosphonate that inhibits osteoclast-mediated bone resorption by binding to hydroxyapatite in bone and suppressing farnesyl pyrophosphate synthase in osteoclasts. [15] This mechanism slows the rate of bone turnover, increases bone mineral density, and reduces fracture risk. The FIT trial demonstrated a 47% reduction in hip fracture risk over 36 months in postmenopausal women with low bone density. [2]

Dose timing directly affects cost because the weekly 70 mg formulation is far cheaper than the daily 10 mg formulation. A 30-tablet supply of alendronate 10 mg (daily dosing) costs approximately $40 to $60 per month at Mississippi pharmacies without a coupon, compared with $15 per month for a 4-tablet supply of 70 mg (weekly dosing). The FDA-approved labeling confirms that both regimens are clinically equivalent in terms of bone mineral density gains, so prescribers and patients in Mississippi should default to weekly dosing unless a specific clinical reason (such as intolerance at the higher single dose) supports daily dosing. [1]

Proper administration also protects the patient from the esophageal adverse effects that generate most alendronate complaints. The tablet must be taken with 6 to 8 ounces of plain water, at least 30 minutes before the first food or drink of the day, while the patient remains upright. Esophageal irritation or, rarely, esophageal ulceration can occur with improper administration. The FDA label and a 2011 FDA Drug Safety Communication both address this risk. [1][16]

Bone Health Guidelines That Drive Prescribing in Mississippi

The AACE 2020 guidelines state: "For postmenopausal women at high risk of fracture, alendronate, risedronate, zoledronic acid, and denosumab are recommended as first-line agents." [3] Because alendronate is available generically at low cost, it remains the most commonly initiated oral bisphosphonate for newly diagnosed osteoporosis in primary care settings across Mississippi.

The U.S. Preventive Services Task Force (USPSTF) recommends screening for osteoporosis with bone measurement testing in women aged 65 and older, and in younger postmenopausal women whose 10-year fracture probability is equal to or greater than that of a 65-year-old White woman without additional risk factors. [17] Mississippi primary care providers following USPSTF guidance and detecting a T-score at or below negative 2.5 will commonly initiate alendronate as a first-line pharmacologic agent.

For men, the Endocrine Society 2012 Clinical Practice Guideline on Osteoporosis in Men recommends alendronate 10 mg daily or 70 mg weekly as a first-line option. [18] The FDA approved alendronate for osteoporosis in men in 2000. [1]

Drug holidays (temporary discontinuation after 5 to 10 years of therapy) are addressed in a 2016 American Society for Bone and Mineral Research task force report, which noted that patients at low-to-moderate fracture risk after 5 years of oral bisphosphonate therapy may safely discontinue and be monitored. [19] This consideration is relevant to Mississippi patients managing long-term medication costs: a supervised drug holiday means zero medication cost for a period, though clinical monitoring (DEXA, FRAX) must continue.

Practical Cost-Reduction Framework for Mississippi Alendronate Patients

A structured approach to minimizing out-of-pocket alendronate cost in Mississippi involves four sequential steps.

Step 1. Confirm the weekly 70 mg formulation. Most Mississippi prescribers default to weekly dosing, but confirming with the prescriber that no clinical reason exists for daily dosing eliminates a 3x to 4x cost premium. Generic alendronate 70 mg is the reference formulation in the FIT trial and in AACE guidelines. [2][3]

Step 2. Run a GoodRx price comparison before presenting at the pharmacy counter. Search by zip code within GoodRx.com or the GoodRx app. In Jackson (zip 39201), the lowest 2026 price for alendronate 70 mg (4 tablets) is typically at Walmart or Costco. Presenting the coupon code at the counter brings the price to $9 to $15. [11]

Step 3. Check Medicare Part D tier if applicable. Patients with Part D coverage should verify that their plan places generic alendronate on Tier 1. If it sits on Tier 2 or higher, requesting a tier exception or switching plans during the next open enrollment period (October 15 to December 7) may save $10 to $20 per month. [4]

Step 4. Ask about 340B pricing at FQHCs. Mississippi patients receiving primary care at an FQHC can often obtain alendronate through the 340B program at a price that may be zero or near zero, depending on the facility's pharmacy dispensing policy. [14]

Running through these four steps sequentially typically brings monthly alendronate cost to $15 or below, and sometimes to zero, for Mississippi patients.

Alendronate Safety Considerations Mississippi Clinicians Should Flag

Contraindications and monitoring requirements affect whether a Mississippi patient can safely use alendronate at any price point.

Alendronate is contraindicated in patients with creatinine clearance below 35 mL per minute, esophageal abnormalities that delay esophageal emptying, and hypocalcemia. The FDA label requires correcting hypocalcemia before initiating therapy. [1] A 2010 FDA Safety Communication identified rare cases of atypical subtrochanteric and diaphyseal femoral fractures associated with long-term bisphosphonate use (generally beyond 5 years). [20] The absolute risk remains low, estimated at 3.2 to 50 cases per 100,000 person-years depending on duration of use, but patients experiencing new thigh or groin pain should be evaluated promptly.

Osteonecrosis of the jaw (ONJ) is a rare adverse effect documented in bisphosphonate users, primarily in patients receiving intravenous bisphosphonates for oncologic indications at doses far exceeding those used for osteoporosis. A 2014 systematic review published in the Journal of Bone and Mineral Research estimated the incidence of ONJ in osteoporosis patients on oral bisphosphonates at 1 in 10,000 to 1 in 100,000 patient-years. [21] Mississippi patients planning dental extractions or implants should inform their dentist of alendronate use.

Serum calcium and 25-hydroxyvitamin D should be within normal limits before initiating alendronate. The Endocrine Society recommends a serum 25-OH vitamin D level of at least 30 ng/mL before starting bisphosphonate therapy, and supplementation to reach that target if levels are insufficient. [18] Given that vitamin D insufficiency is prevalent across Mississippi, where outdoor physical activity is limited by heat for much of the year, checking this lab before prescribing alendronate is a practical clinical step that can prevent the hypocalcemia that sometimes causes early discontinuation.

Frequently asked questions

How much does Fosamax cost in Mississippi?
Generic alendronate 70 mg (4 tablets, one-month supply) costs approximately $15 per month at major Mississippi retail pharmacies in 2026 when a GoodRx or similar discount coupon is used. Brand-name Fosamax has a list price near $80 per month, but almost no patients pay that amount. Without any coupon, the generic may cost $20 to $35 depending on the pharmacy.
Does Mississippi Medicaid cover Fosamax?
Mississippi Medicaid does not routinely cover Fosamax or generic alendronate for outpatient osteoporosis under the 2026 preferred drug list. A prior authorization request supported by DEXA scan results (T-score at or below negative 2.5) or documented fragility fracture may allow coverage in some cases. Dual-eligible patients should check their Medicare Part D plan, which more commonly covers generic alendronate on Tier 1.
Is compounded alendronate legal in Mississippi?
Yes, a Mississippi-licensed 503A compounding pharmacy can legally compound alendronate for an individual patient with a valid patient-specific prescription from a licensed prescriber. The compounded product is not FDA-approved, so a clinical rationale (such as dysphagia or excipient allergy) should be documented. Because commercial generic alendronate is widely available and inexpensive, 503A compounding is appropriate only when a specific patient need cannot be met by the commercial product.
Can I get Fosamax via telehealth in Mississippi?
Yes. Mississippi law permits synchronous audio-visual telehealth visits to establish a prescriber-patient relationship, and alendronate (a non-controlled substance) can be prescribed following that visit. The prescriber must be licensed in Mississippi or hold a Mississippi telehealth license. A telehealth visit for osteoporosis typically includes review of DEXA results, FRAX score, serum calcium, vitamin D level, and renal function.
Which insurance plans cover Fosamax in Mississippi?
Most commercial plans in Mississippi, including BlueCross BlueShield of Mississippi, Humana, Aetna, and United Healthcare, cover generic alendronate on Tier 1 or Tier 2, with copays of $5 to $20 per month. Brand Fosamax is rarely on a preferred tier; insurers require generic-first step therapy. Patients whose plan places generic alendronate on Tier 3 or higher can request a formulary exception with a letter of medical necessity.
What's the cheapest way to get Fosamax in Mississippi?
The cheapest options in order are: (1) 340B-linked pharmacy at a Mississippi Federally Qualified Health Center, which may offer alendronate at no cost; (2) Medicare Extra Help, which caps generic copays at $4.50 per month; (3) GoodRx coupon at Walmart or Costco, yielding $9 to $15 per month; and (4) standard generic purchase with coupon at major chains at $14 to $17 per month.
Are there Mississippi Fosamax discount programs?
Yes. GoodRx, RxSaver, and Blink Health offer free discount coupons that reduce generic alendronate to $9 to $15 per month at Mississippi pharmacies. Medicare Extra Help (Low Income Subsidy) caps costs at $4.50 per generic prescription. The 340B Drug Pricing Program at Federally Qualified Health Centers in Mississippi may offer the drug at minimal or no cost to qualifying patients. Merck's patient assistance program covers brand Fosamax for income-qualifying uninsured patients.
How does the Merck savings card work in Mississippi?
Merck offers a patient assistance program for brand Fosamax, primarily for uninsured or underinsured patients below 400% of the federal poverty level. Because generic alendronate is available at $15 per month or less, most Mississippi patients do not need the brand savings card. Patients who have a documented medical reason for the brand product should apply through Merck's official patient assistance portal. The program is not accepted at all Mississippi pharmacies, so calling ahead to confirm participation is necessary.

References

  1. U.S. Food and Drug Administration. Fosamax (alendronate sodium) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/019584s059lbl.pdf
  2. Black DM, Cummings SR, Karpf DB, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial (FIT). JAMA. 1998;279(6):432-437. https://pubmed.ncbi.nlm.nih.gov/9847152/
  3. Camacho PM, Petak SM, Binkley N, et al. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis. Endocr Pract. 2020;26(Suppl 1):1-46. https://pubmed.ncbi.nlm.nih.gov/32427503/
  4. Centers for Medicare and Medicaid Services. Medicare Part D drug coverage. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn
  5. Larsen JB, Gammelager H, Kristensen NR, et al. Bisphosphonate treatment and risk of cardiovascular events and mortality in patients with osteoporosis. Eur Heart J. 2022;43(21):1982-1993. https://pubmed.ncbi.nlm.nih.gov/35267038/
  6. U.S. Food and Drug Administration. Compounding: 503A compounding pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
  7. U.S. Food and Drug Administration. Guidance for industry: Caveats to compounding under section 503A of the Federal Food, Drug, and Cosmetic Act. https://www.fda.gov/media/94542/download
  8. Mississippi State Department of Health. Telehealth in Mississippi. https://msdh.ms.gov/msdhsite/index.cfm/44,0,388,html
  9. World Health Organization. FRAX: Fracture Risk Assessment Tool. https://www.who.int/news/item/20-02-2008-who-collaborating-centre-for-metabolic-bone-diseases
  10. Bone Health and Osteoporosis Foundation. Calcium and vitamin D: What you need to know. https://www.bonehealthandosteoporosis.org/patients/treatment/calciumvitamin-d/
  11. GoodRx. Alendronate price and coupons. https://www.goodrx.com/alendronate
  12. Merck. Merck patient assistance program. https://www.merck.com/patient-assistance-program/
  13. Social Security Administration. Extra Help with Medicare prescription drug plan costs. https://www.ssa.gov/medicare/part-d-extra-help
  14. Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa/index.html
  15. Rogers MJ, Crockett JC, Coxon FP, Monkkonen J. Biochemical and molecular mechanisms of action of bisphosphonates. Bone. 2011;49(1):34-41. https://pubmed.ncbi.nlm.nih.gov/21333753/
  16. U.S. Food and Drug Administration. FDA Drug Safety Communication: Ongoing safety review of oral bisphosphonates and atypical subtrochanteric femur fractures. 2010. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-ongoing-safety-review-oral-bisphosphonates-and-atypical
  17. U.S. Preventive Services Task Force. Osteoporosis to prevent fractures: Screening. 2018. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
  18. Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(6):1802-1822. https://pubmed.ncbi.nlm.nih.gov/22675062/
  19. Adler RA, El-Hajj Fuleihan G, Bauer DC, et al. Managing osteoporosis in patients on long-term bisphosphonate treatment: Report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2016;31(1):16-35. https://pubmed.ncbi.nlm.nih.gov/26350171/
  20. U.S. Food and Drug Administration. FDA Drug Safety Communication: Safety update for osteoporosis drugs, bisphosphonates, and atypical fractures. 2010. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-safety-update-osteoporosis-drugs-bisphosphonates-and-atypical
  21. Khan AA, Morrison A, Hanley DA, et al. Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus. J Bone Miner Res. 2015;30(1):3-23. https://pubmed.ncbi.nlm.nih.gov/25414052/